End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3,775 KRW | -0.40% | -0.53% | -8.15% |
2023 | Tranche Update on Hyundai Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 14, 2023. | CI |
2023 | Hyundai Pharmaceutical Co., Ltd.(KOSE:A004310) dropped from S&P Global BMI Index | CI |
Sales 2012 | 102B 74.64M 6.24B | Sales 2013 | 108B 78.94M 6.59B | Capitalization | 42.44B 30.98M 2.59B |
---|---|---|---|---|---|
Net income 2012 | -4.85B -3.54M -296M | Net income 2013 | 1.42B 1.03M 86.28M | EV / Sales 2012 | 0.48 x |
Net Debt 2012 | 12.68B 9.25M 773M | Net Debt 2013 | 6.12B 4.47M 373M | EV / Sales 2013 | 0.45 x |
P/E ratio 2012 |
-7.47
x | P/E ratio 2013 |
30
x | Employees | 393 |
Yield 2012 |
2.39% | Yield 2013 |
2.32% | Free-Float | 58.96% |
1 day | -0.40% | ||
1 week | -0.53% | ||
Current month | -0.13% | ||
1 month | -0.40% | ||
3 months | -1.69% | ||
6 months | -5.51% | ||
Current year | -8.15% |
Managers | Title | Age | Since |
---|---|---|---|
Sang-Joon Lee
CEO | Chief Executive Officer | 47 | 28/03/28 |
Seok-Bong Lee
DFI | Director of Finance/CFO | 67 | 08/89/08 |
Young-Hak Kim
BRD | Director/Board Member | 62 | 23/07/23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Han-Gu Lee
CHM | Chairman | 76 | 09/74/09 |
Cheon-Soo Ham
BRD | Director/Board Member | 77 | 05/99/05 |
Sang-Joon Lee
CEO | Chief Executive Officer | 47 | 28/03/28 |
Date | Price | Change | Volume |
---|---|---|---|
10/24/10 | 3,775 | -0.40% | 18,543 |
09/24/09 | 3,790 | -0.26% | 20,775 |
08/24/08 | 3,800 | 0.00% | 16,888 |
07/24/07 | 3,800 | +0.40% | 59,872 |
03/24/03 | 3,785 | -0.26% | 28,167 |
End-of-day quote Korea S.E., May 10, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-8.15% | 76.29M | |
+19.62% | 43.27B | |
+24.52% | 22.92B | |
+20.29% | 15.43B | |
+7.48% | 12.95B | |
+42.51% | 11.83B | |
-8.84% | 6.91B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.13% | 5.55B |
- Stock Market
- Equities
- A004310 Stock